Radiopharmaceutical Pluvicto, Locametz, Lutathera and Netspot Injections
Closed Special Notice Posted
- Solicitation number
- HT941026N0009
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- San Diego, California, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency has issued a Special Notice (HT941026N0009) regarding the procurement of radiopharmaceutical injections, specifically Pluvicto, Locametz, Lutathera, and Netspot, for use across multiple Military Treatment Facilities (MTFs). Posted on November 19, 2025, this notice indicates the agency's intent to pursue a sole source acquisition for these pharmaceutical products. The opportunity falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals). This Special Notice serves as advance notification to the contracting community and allows for potential challenges to the sole source justification prior to final contract award.
The primary objective of this procurement is to secure a reliable supply of these specialized radiopharmaceutical injections for medical use within the Defense Health System. Contractors interested in challenging the sole source determination must submit their notices of intent by the December 9, 2025 deadline. The notice appears to target pharmaceutical manufacturers capable of producing or supplying these specific radiopharmaceutical products to federal healthcare facilities. While the attached Notice of Intent document contains the detailed justification for the sole source approach, interested vendors should review the complete documentation to understand the specific requirements and any potential opportunities to demonstrate capability or eligibility to supply these products. Contractors seeking to participate should ensure they possess the necessary regulatory approvals, manufacturing capabilities, and distribution networks required to meet the Defense Health Agency's pharmaceutical supply requirements.
Notice text
See attached: Notice of Intent to Sole Source HT941026N0009
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Radiopharmaceuticals Base Plus Four Option Years VA San Diego Healthcare System | Veterans Integrated Service Network 22 | No set-aside | |
| Notice of intent to award a sole source | Naval Supply Systems Command | No set-aside | |
| Notice of Intent to Sole Source to Mediso USA | Uniformed Services University of the Health Sciences | No set-aside | |
| Presolicitation Notice PowerScribe Maintenance | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity